Baker Hughes ends September under pressure: the stock has shed 10% over the past month to $55.92, reversing the bullish momentum that characterised much of the summer, and the analyst community responded this week with a cluster of target cuts that confirm the Street is recalibrating but not retreating.
The most notable shift came from three firms in two days. Goldman Sachs reinstated coverage on September 29 with a Buy and a $71 target, a constructive signal on its own. But Jefferies trimmed its target from $80 to $77 on the same day while keeping its Buy, and UBS followed on September 30 by cutting from $72 to $69 while holding Neutral. The pattern across the broader recent-changes list is consistent: bulls remain bulls, but price targets are coming in. The consensus mean target is now $71.92, implying roughly 29% upside from current levels. Fifteen analysts carry Buy-equivalent ratings, and none in the recent activity switched to a Sell. The direction of travel is target compression rather than conviction loss.
The bull case rests on Baker Hughes's post-2022 restructuring, which broadened the earnings mix beyond pure oilfield services into industrial and energy technology. The pending Chart Industries acquisition is modelled to add 11% EPS accretion by 2027, lift consolidated EBITDA margins, and bring $325 million in annualised cost synergies within three years. The bear case is equally clear: the oilfield services and equipment segment remains cyclically exposed to upstream capex discipline, and the IET transition to power and data-centre markets still carries execution risk. Valuation gives neither side an easy win. The P/E has compressed by 2.2 points over the past month to 19.1x, and EV/EBITDA has edged down to 9.9x. The 90-day EPS momentum factor scores in the 76th percentile, but the 30-day reading has dropped to the 23rd, reflecting the recent derating. The analyst recommendation differential factor scores at the 89th percentile, meaning the consensus is more constructive on BKR than on nearly all its sector peers.
The lending market is sending a different message: there is essentially no short-selling pressure here. Short interest has fallen 15.5% over the past week to 2.3% of free float, continuing a decline that began from around 2.7% in mid-September. Shares available to borrow are effectively unlimited. The ORTEX short score has drifted lower all week, closing at 32.3 on September 29, its lowest reading of the period shown and well below any level that would flag meaningful speculative interest against the stock. Borrowing costs rose 53% week-on-week to 0.50%, but from such a low base the absolute level remains trivial. Options positioning has turned more defensive than last week's note described: the put/call ratio has climbed to 0.74, just above one standard deviation above its 20-day average of 0.70. That is a reversal from the bullish 0.65 reading that characterised the stock on September 26. It is not yet alarming, the 52-week high is 1.18, but the direction shifted sharply in the final session of the month, likely tracking the broader sector selloff on September 29.
Peers confirm this was a sector-wide move rather than a BKR-specific event. SLB fell 3.1% on the day and 4.3% on the week. HAL dropped 2.7% on the day and 4.0% on the week. NOV declined 2.7% on the day and 5.9% on the week. Baker Hughes's 2.3% daily decline was at the milder end of the peer group, consistent with its relative outperformance through most of September. The stock's Wikipedia attention z-score hit 2.0 in the week ending September 22, above the top of its own 90-day range, suggesting the September pullback has drawn retail interest back to the name.
Institutional flows are broadly supportive. JP Morgan Asset Management added nearly 9.7 million shares in its most recently reported period, the largest single addition among the top-15 holders. BlackRock and State Street also added in the same window. No holder in the 13D/G register carries activist status; all filings are passive 13G disclosures, with JPMorgan Chase's stake now at 6.9%, up from 5.8% in its prior filing.
Q3 earnings are set for October 23. With short interest negligible, targets trimmed but not abandoned, and the peer group under renewed pressure from energy market softness, the key question into that print is whether IET order momentum and the Chart deal rationale can offset any cyclical weakness in the oilfield services segment.
See the live data behind this article on ORTEX.
Open BKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
